13156 Federal Register / Vol. 62, No. 53 / Wednesday, March 19, 1997 / Notices

1Copies of the Complaint and the Decision and

Order are available from the Commission’s Public

Reference Branch, H–130, 6th Street & Pennsylvania

Avenue, N.W., Washington, D.C. 20580.

1Copies of the Complaint and the Decision and

Order are available from the Commission’s Public

Reference Branch, H–130, 6th Street & Pennsylvania

Avenue, N.W., Washington, D.C. 20580.

FOR FURTHER INFORMATION CONTACT:

George Carey, FTC/H–374, Washington,

DC 20580. (202) 326–3741.

SUPPLEMENTARY INFORMATION: On

Monday, December 16, 1996, there was

published in the Federal Register, 61 FR

66041, a proposed consent agreement

with analysis In the Matter of J.C.

Penney Company, Inc., et al., for the

purpose of soliciting public comment.

Interested parties were given sixty (60)

days in which to submit comments,

suggestions or objections regarding the

proposed form of the order.

No comments having been received,

the Commission has ordered the

issuance of the complaint in the form

contemplated by the agreement, made

its jurisdictional findings and entered

an order to divest, as set forth in the

proposed consent agreement, in

disposition of this proceeding.

(Sec. 6, 38 Stat. 721; 15 U.S.C. 46. Interpret

or apply sec. 5, 38 Stat. 719, as amended; sec.

7, 38 Stat. 731, as amended; 15 U.S.C. 45, 18)

Benjamin I. Berman,

Acting Secretary.

[FR Doc. 97–6914 Filed 3–18–97; 8:45 am]

BILLING CODE 6750–01–M

[Dkt. C–3721]

J.C. Penney Company, Inc., et al.;

Prohibited Trade Practices, and

Affirmative Corrective Actions

AGENCY: Federal Trade Commission.

ACTION: Consent order.

SUMMARY: In settlement of alleged

violations of federal law prohibiting

unfair or deceptive acts or practices and

unfair methods of competition, this

consent order requires, among other

things, J.C. Penney and Thrift Drugs, its

wholly-owned subsidiary, to divest by

March 21, 1997, to a Commissionapproved acquirer, a total of 161 drug

stores in North and South Carolina. The

consent order settles allegations that J.C.

Penney’s proposed acquisition of Eckerd

Corporation, and 190 Rite Aid drug

stores in these two states, violated

antitrust laws by substantially reducing

drug store competition.

DATES: Complaint and Order issued

February 28, 1997.1

FOR FURTHER INFORMATION CONTACT:

George Carey, FTC/H–374, Washington,

D.C. 20580. (202) 326–3741.

SUPPLEMENTARY INFORMATION: On

Monday, December 16, 1996, there was

published in the Federal Register, 61 FR

66041, a proposed consent agreement

with analysis In the Matter of J.C.

Penney Company, Inc., et al., for the

purpose of soliciting public comment.

Interested parties were given sixty (60)

days in which to submit comments,

suggestions or objections regarding the

proposed form of the order.

No comments having been received,

the Commission has ordered the

issuance of the complaint in the form

contemplated by the agreement, made

its jurisdictional findings and entered

an order to divest, as set forth in the

proposed consent agreement, in

disposition of this proceeding.

(Sec. 6, 38 Stat. 721; 15 U.S.C. 46. Interpret

or apply sec. 5, 38 Stat. 719, as amended; sec.

7, 38 Stat. 731, as amended; 15 U.S.C. 45, 18)

Benjamin I. Berman,

Acting Secretary.

[FR Doc. 97–6915 Filed 3–18–97; 8:45 am]

BILLING CODE 6750–01–M

[Dkt. C–3720]

Premier Products, Inc, et al.;

Prohibited Trade Practices, and

Affirmative Corrective Actions

AGENCY: Federal Trade Commission.

ACTION: Consent order.

SUMMARY: In settlement of alleged

violations of federal law prohibiting

unfair or deceptive acts or practices and

unfair methods of competition, this

consent order prohibits, among other

things, the New Jersey-based

corporations, that advertise ‘‘Miracle

Thaw’’ food thawing trays, the their

officers from misrepresenting, with

respect to any product involving the

storage or preparation of food, the risk

of buildup of harmful and unsafe levels

of bacteria on food items defrosted,

thawed, prepared, or stored using the

product; the amount of time it may take

to defrost, thaw, or prepare food items

using the product; the process by which

the product achieves any claimed

defrosting, thawing, or preparation

times; or the existence, contents,

validity, results, conclusions, or

interpretations of any test, study, or

research.

DATES: Complaint and Order issued

February 26, 1997.1

FOR FURTHER INFORMATION CONTACT:

Phoebe Morse, Federal Trade

Commission, Boston Regional Office,

101 Merrimac Street, Suite 810, Boston,

MA. 02114–4719. (617) 424–5960.

SUPPLEMENTARY INFORMATION: On

Monday, December 16, 1996, there was

published in the Federal Register, 61 FR

66043, a proposed consent agreement

with analysis In the Matter of Premier

Products, Inc., et al., for the purpose of

soliciting public comment. Interested

parties were given sixty (60) days in

which to submit comments, suggestions

or objections regarding the proposed

form of the order.

No comments having been received,

the Commission has ordered the

issuance of the complaint in the form

contemplated by the agreement, made

its juridicational findings and entered

an order to cease and desist, as set forth

in the proposed consent agreement, in

disposition of this proceeding.

(Sec. 6, 38 Stat. 721; 15 U.S.C. 46, Interprets

or applies sec. 5, 38 Stat. 719, as amended;

15 U.S.C. 45)

Benjamin I. Berman,

Acting Secretary.

[FR Doc. 97–6916 Filed 3–18–97; 8:45 am]

BILLING CODE 6750–01–M

GENERAL ACCOUNTING OFFICE

Federal Accounting Standards

Advisory Board

AGENCY: General Accounting Office.

ACTION: Notice of meeting.

SUMMARY: Pursuant to section 10(a)(2) of

the Federal Advisory Committee Act

(Pub. L. 92–463), as amended, notice is

hereby given that the Federal

Accounting Standards Advisory Board

will meet on Thursday, March 27, 1997,

from 9:00 a.m. to 4:00 p.m. in room

7C13 of the General Accounting Office

building, 441 G Street, NW.,

Washington, DC.

The purpose of the meeting is to

discuss the following issues: (1) Social

insurance, (2) software development

costs, (3) expense/expenditure, and (4)

environmental liabilities.

Any interested person may attend the

meeting as an observer. Board

discussions and reviews are open to the

public.

FOR FURTHER INFORMATION CONTACT:

Wendy Comes, Executive Director, 750

First St., NE., Room 1001, Washington,

DC 20002, or call (202) 512–7350.

Authority: Federal Advisory Committee

Act. Pub. L. No. 92–463, Section 10(a)(2), 86

Stat. 770, 774 (1972) (current version at 5

U.S.C. app. section 10(a)(2) (1988); 41 CFR

101–6.1015 (1990).
Federal Register / Vol. 62, No. 53 / Wednesday, March 19, 1997 / Notices 13157

Dated: March 14, 1997.

Wendy M. Comes,

Executive Director.

[FR Doc. 97–6913 Filed 3–18–97; 8:45 am]

BILLING CODE 1610–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

[30 DAY–197]

Agency Forms Undergoing Paperwork

Reduction Act Review

The Centers for Disease Control and

Prevention (CDC) publishes a list of

information collection requests under

review by the Office of Management and

Budget (OMB) in compliance with the

Paperwork Reduction Act (44 U.S.C.

Chapter 35). To request a copy of these

requests, call the CDC Reports Clearance

Office on (404) 639–7090. Send written

comments to CDC, Desk Officer; Human

Resources and Housing Branch, New

Executive Office Building, Room 10235;

Washington, DC 20503. Written

comments should be received within 30

days of this notice.

The following requests have been

submitted for review since the last

publication date on March 12, 1997.

Proposed Project

1. Examination of Barriers to

Participant Compliance in a Flexible

Sigmoidoscopy Screening Program.

Kaiser Foundation, Oakland—New—

With colorectal cancer comprising the

second highest mortality rate among all

U.S. cancers and ranked as the fourth

most common form of cancer, the active

promotion of population-based

screening and early detection is

becoming increasingly important.

Recognizing the importance of

screening, American Cancer Society

guidelines and the new US Preventive

Services Task Force guidelines

recommend colorectal cancer screening

for individuals over the age of 50. Still,

although early detection of colorectal

neoplasms has been effectively

demonstrated to significantly reduce

morbidity and mortality and associated

economic costs, compliance is very low.

This three-year study involving

investigators at one of the nation’s

largest Health Maintenance

Organizations’’ research foundation

(Kaiser Foundation of Northern

California) seeks to identify barriers

associated with low compliance in a

colorectal cancer screening program

utilizing flexible sigmoidoscopy.

Phase I will target and recruit

participants from an existing pool of

Health Maintenance Organization

enrollees who are at a relatively high

age-related risk (ages 50–64) for

developing colorectal cancers via short

survey and invitation to screening. In

Phase II, investigators will conduct a

telephone survey to identify the relative

impact of economic, psychological, and

related factors on participation and nonparticipation in the mass screening

programs. In phase III, investigators will

analyze and widely disseminate results

of the study via publication in the

professional literature. Results will also

be made available to participants upon

request. Interventions designed to

mitigate the barriers identified through

this study will be incorporated into

future screening efforts and general

health education/health promotion

efforts.

Participation in this study is

voluntary and subsequent follow-up and

treatment, if indicated, will be provided

at no cost to participants. Informed

consent will be obtained where

appropriate and oversight will be

provided by federal and institutional

review. The total annual burden hours

are 2,141.

Respondents Number of

respondents

Number of

responses/

respondent

Average

burden/response

(in hrs.)

HMO Enrollees ......................................................................................................................................... 6165 1 .3473

2. Reliability and Validity Assessment

of the Use of Scales of Stressful Life

Events in Black Women of Reproductive

Age (0920–0356)—Extension—A CDC

review of studies of psychosocial factors

and adverse pregnancy outcome

supports the hypothesis that high levels

of exposure to stressful life experiences

put black women at increased risk for

adverse reproductive outcome,

particularly Preterm Delivery (PTD) and

Very Low Birth Weight (VLBW). The

purpose of this study is to evaluate the

reliability and validity of existing

instruments that measure stressful life

events in black women of reproductive

age. Respondents will consist of

reproductive age residents who live in

the Atlanta area and may attend a health

care facility that has a behavioral

prenatal unit. Approximately one half

the women will be pregnant at the time

of data collection.

Women enrolled in the study respond

to a series of demographic and

psychosocial questionnaires. They also

ask that women provide a 24 hour urine

sample and saliva sample. Both samples

are used to correlate reported levels of

stress with laboratory measures of

stress.

Participation in this study is

voluntary and participants will receive

a reimbursement for their time. A

written informed consent will be

obtained and local institutional review

will provide oversight.

The study is ongoing and by

December 31, 1996, approximately twothirds of data collected was completed.

Approximately 130 women need to be

interviewed. This leaves 130 women in

the validity study, of which 30 women

will repeat the process for the reliability

study. The total annual burden hours

are 1,134.

Respondents Number of

respondents

Number of

responses/

respondent

Average burden/response

(in hrs.)

Total burden

(in hrs.)

Screening ........................................................................................................................ 300 1 .083 25

Validity study group—African-American Women for the ages of 18 to 45 .................... 100 1 7.07 707

Reliability study group—African-American Women for the ages of 18 to 45 ................ 30 1 13.4 402